Other News To Note

 Can-Fite BioPharma Ltd., of Petach, Israel, said it designated CF603, an A3 adenosine receptor allosteric modulator licensed from Leiden University, to be developed for the treatment of sexual dysfunction. Recent studies showed that adenosine functions to relax the corpus cavernosum and promote penile erection.